Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design

Tumor progression is a surrogate of survival but its impact varies according to progression pattern. Thus, PPS is influenced by progression pattern and this is key in prognostic prediction and second-line trial design and analysis.